Latest Lead News

Cyprium Metals has raised A$41 million through an oversubscribed equity placement and entitlement offer to accelerate exploration and production growth at its flagship Nifty Copper Complex and regional projects.

Codeifai Limited has raised $1.1 million through a share placement to fund the commercialisation of a quantum-secured platform and broaden its AI capabilities into new industrial sectors.

ABx Group has reported exceptional rare earth extraction rates exceeding 80% from column leach tests on bulk samples at its Deep Leads project, suggesting heap leaching could outperform traditional tank methods and accelerate commercial production.

Impact Minerals has acquired a 55 sq km tenement covering the historic Huonville gold district near Broken Hill, significantly expanding its landholding and advancing its exploration for copper-gold deposits.

WiseTech Global has announced its key financial and governance dates for FY26, highlighting its ongoing commitment to innovation and global logistics software dominance.

King River Resources advances exploration with new drill and soil sampling results at Tennant Creek, revealing promising IOCG-style mineralisation corridors and appointing a new Managing Director.

Lincoln Minerals has identified historic high-grade copper and gold samples at its Southern Eyre Project, complementing significant copper mineralisation confirmed at its flagship Minbrie Project in South Australia.

Anteris Technologies has closed a $320 million capital raise, combining a $230 million public offering and a strategic private placement with Medtronic, to advance its DurAVR heart valve clinical trials and manufacturing growth.

Anteris Technologies Global Corp. has entered a material definitive agreement to raise approximately $320 million through a public offering and a strategic private placement with Medtronic’s subsidiary. The capital will support clinical trials and manufacturing expansion for its innovative heart valve technology.

Cambium Bio has strengthened its financial footing with a $0.6 million R&D tax refund and a $2.4 million strategic placement, setting the stage for pivotal Phase 3 clinical trials of its lead ophthalmology candidate.

Guzman y Gomez has secured a multi-year exclusive delivery partnership with Uber Eats in Australia, aiming to accelerate growth and enhance customer convenience. Delivery now accounts for over a quarter of GYG’s Australian sales, underscoring its strategic importance.

Arovella Therapeutics has filed an IND application for its lead CAR-iNKT therapy ALA-101, selected a CRO for its upcoming phase 1 trial, and secured $19.4 million in cash to fund clinical progress and pipeline expansion.